Piscataway, NJ, April 26, 2023– Camber Pharmaceuticals is pleased to announce the addition of Zileuton ER Tablets to its current portfolio.
Zileuton ER Tablets are indicated for the prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older. Zileuton ER Tablets are not indicated for use in the reversal of bronchospasm in acute asthma attacks. Therapy with Zileuton ER Tablets can be continued during acute exacerbations of asthma.
Zileuton ER Tablets are available in 600 mg strength in 120 count bottles.
To find out more about Zileuton ER Tablets please visit www.camberpharma.com
Camber Pharmaceuticals is a fully integrated pharmaceutical company. Its parent company, Hetero, of Hyderabad, India, is one of the world’s leading API and finished dosage manufacturers. Camber is committed to bringing the highest quality generic pharmaceuticals to consumers, improving quality of life through cost-effective medications.
# # #
If you would like more information about this topic, please contact Megan Little at [email protected]
